Affinity Asset Advisors’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-100,000
| Closed | -$2.89M | – | 120 |
|
|
2025
Q4 | $2.89M | Buy |
+100,000
| New | +$1.9M | 0.21% | 75 |
|
|
2024
Q3 | – | Sell |
-30,680
| Closed | -$1.54M | – | 101 |
|
|
2024
Q2 | $1.54M | Sell |
30,680
-9,320
| -23% | -$674K | 0.24% | 71 |
|
|
2024
Q1 | $4.48M | Hold |
40,000
| – | – | 0.73% | 53 |
|
|
2023
Q4 | $2.32M | Sell |
40,000
-74,000
| -65% | -$2.98M | 0.46% | 54 |
|
|
2023
Q3 | $3.62M | Buy |
+114,000
| New | +$5.42M | 1.18% | 34 |
|
|
2021
Q3 | – | Sell |
-3,400
| Closed | -$1.15M | – | 94 |
|
|
2021
Q2 | $1.15M | Hold |
3,400
| – | – | 0.55% | 50 |
|
|
2021
Q1 | $1.38M | Buy |
3,400
+1,400
| +70% | +$679K | 0.67% | 43 |
|
|
2020
Q4 | $1.33M | Buy |
+2,000
| New | +$1.11M | 0.82% | 36 |
|